Vantage Investment Partners, LLC Eli Lilly & CO Transaction History

Vantage Investment Partners, LLC

$1.19 Billion
Q3 2024

A detailed history of Vantage Investment Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Vantage Investment Partners, LLC holds 16,378 shares of LLY stock, worth $13 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares

16,378

Previous 17,981 8.91%

Holding current value

$13 Million

Previous $16.3 Million 10.87%

% of portfolio

1.22%

Previous 1.48%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$772.14 - $960.02 $1.24 Million - $1.54 Million	-1,603 Reduced 8.91%	16,378 $14.5 Million
Q2 2024 Jul 29, 2024	SELL	$724.87 - $909.04 $1.82 Million - $2.28 Million	-2,505 Reduced 12.23%	17,981 $16.3 Million
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $5.46 Million - $7.31 Million	-9,227 Reduced 31.05%	20,486 $15.9 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $735,791 - $867,401	-1,401 Reduced 4.5%	29,713 $17.3 Million
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $285,163 - $393,140	656 Added 2.15%	31,114 $16.7 Million
Q2 2023 Jul 24, 2023	SELL	$350.74 - $468.98 $4.01 Million - $5.36 Million	-11,427 Reduced 27.28%	30,458 $14.3 Million
Q1 2023 Apr 18, 2023	BUY	$310.63 - $364.82 $157,800 - $185,328	508 Added 1.23%	41,885 $14.4 Million
Q4 2022 Jan 27, 2023	BUY	$321.55 - $374.67 $100,323 - $116,897	312 Added 0.76%	41,377 $15.1 Million
Q3 2022 Oct 18, 2022	BUY	$296.48 - $337.87 $33,205 - $37,841	112 Added 0.27%	41,065 $13.3 Million
Q2 2022 Jul 28, 2022	SELL	$278.73 - $327.27 $1.49 Million - $1.75 Million	-5,341 Reduced 11.54%	40,953 $13.3 Million
Q1 2022 Apr 22, 2022	BUY	$234.69 - $291.66 $93,171 - $115,789	397 Added 0.86%	46,294 $13.3 Million
Q4 2021 Jan 21, 2022	BUY	$224.85 - $279.04 $936,275 - $1.16 Million	4,164 Added 9.98%	45,897 $12.7 Million
Q3 2021 Oct 13, 2021	SELL	$221.6 - $272.71 $3.71 Million - $4.57 Million	-16,754 Reduced 28.65%	41,733 $9.64 Million
Q2 2021 Jul 29, 2021	BUY	$180.55 - $233.54 $2.32 Million - $3 Million	12,865 Added 28.2%	58,487 $13.4 Million
Q1 2021 May 03, 2021	SELL	$164.32 - $212.72 $4.72 Million - $6.11 Million	-28,716 Reduced 38.63%	45,622 $8.52 Million
Q4 2020 Jan 25, 2021	SELL	$130.46 - $172.63 $2.4 Million - $3.17 Million	-18,377 Reduced 19.82%	74,338 $12.6 Million
Q3 2020 Oct 22, 2020	BUY	$146.22 - $169.13 $342,154 - $395,764	2,340 Added 2.59%	92,715 $13.7 Million
Q2 2020 Jul 21, 2020	BUY	$136.42 - $164.18 $415,398 - $499,928	3,045 Added 3.49%	90,375 $14.8 Million
Q1 2020 Apr 28, 2020	BUY	$119.05 - $147.35 $183,813 - $227,508	1,544 Added 1.8%	87,330 $12.1 Million
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $13,899 - $17,215	130 Added 0.15%	85,786 $11.3 Million
Q3 2019 Oct 24, 2019	BUY	$106.79 - $116.16 $1,495 - $1,626	14 Added 0.02%	85,656 $9.58 Million
Q2 2019 Aug 07, 2019	SELL	$110.79 - $129.32 $1.78 Million - $2.07 Million	-16,034 Reduced 15.77%	85,642 $9.49 Million
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $2,114 - $2,489	19 Added 0.02%	101,676 $13.2 Million
Q4 2018 Feb 06, 2019	SELL	$105.9 - $118.64 $158,320 - $177,366	-1,495 Reduced 1.45%	101,657 $11.8 Million
Q3 2018 Oct 31, 2018	SELL	$85.86 - $107.31 $516,533 - $645,576	-6,016 Reduced 5.51%	103,152 $11.1 Million
Q2 2018 Aug 01, 2018	SELL	$75.7 - $86.88 $2.55 Million - $2.92 Million	-33,621 Reduced 23.55%	109,168 $9.31 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $1.45 Million - $1.71 Million	19,513 Added 15.83%	142,789 $11 Million
Q4 2017 Feb 15, 2018	BUY	$81.94 - $87.89 $9.09 Million - $9.75 Million	110,949 Added 900.05%	123,276 $10.4 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $10.8 Million - $11.6 Million	-131,943 Reduced 91.46%	12,327 $1.04 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $345,196 - $383,133	-4,479 Reduced 3.01%	144,270 $12.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	148,749	148,749 $12.2 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Investment Partners, LLC with notifications on news.

Account

Vantage Investment Partners, LLC Eli Lilly & CO Transaction History